SARS-CoV-2 Mpro

Lanlan Jing1, Fabao Zhao1, Lin Zheng1

  • 1Key Laboratory of Chemical Biology (Ministry of Education), Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 West Culture Road, Jinan 250012, China.

概括

研究人员通过选针对Mpro酶的化合物开发了新的潜在抗SARS-CoV-2药物. 化合物A9显示出强烈的抗病毒活性,使其成为未来针对COVID-19的药物开发的有希望的候选人.